Mixed Tumor, MesodermalOvarian NeoplasmsFallopian TubesFallopian Tube NeoplasmsOvaryFallopian Tube DiseasesFallopian Tube Patency TestsNeoplasms, Glandular and EpithelialCystadenocarcinoma, SerousPregnancy, TubalPeritoneal NeoplasmsHysterosalpingographySalpingitisGenes, BRCA1CA-125 AntigenSterilization, TubalSalpingectomyPregnancy, EctopicGenes, BRCA2Torsion AbnormalityDrug Resistance, NeoplasmInfertility, FemaleCarcinomaCarcinoma, EndometrioidCystadenoma, SerousCell Line, TumorAdenocarcinoma, Clear CellGene Expression Regulation, NeoplasticEarly Detection of CancerAntineoplastic AgentsPaclitaxelAntineoplastic Combined Chemotherapy ProtocolsTumor Markers, BiologicalBRCA2 ProteinPolycystic Ovary SyndromeNeoplasm StagingBreast NeoplasmsImmunohistochemistryPelvic NeoplasmsTreatment OutcomePollen TubeBRCA1 ProteinGenitalia, FemalePrognosisGenital Neoplasms, FemaleRNA, MessengerReverse Transcriptase Polymerase Chain ReactionCarboplatinMice, NudeCisplatinAnemia, RefractoryNeoplasm ProteinsMutationNeoplasm InvasivenessEpithelial CellsRefractory Period, ElectrophysiologicalNeoplasm Recurrence, LocalCiliaEpitheliumGenetic Predisposition to DiseaseNeural Tube DefectsRetrospective StudiesAscitesSurvival AnalysisGerm-Line MutationEndometrial NeoplasmsNeoplasmsAdenocarcinoma, PapillaryPregnancyMenstrual CycleProstatic NeoplasmsDisease-Free SurvivalFollow-Up StudiesNeoplasm MetastasisGene Expression ProfilingUrogenital Surgical ProceduresProspective StudiesAdenocarcinoma, MucinousCystadenocarcinoma, MucinousSurvival RateGynecologic Surgical ProceduresBlotting, WesternXenograft Model Antitumor AssaysProlapseCell ProliferationLung NeoplasmsHysterectomyAntineoplastic Agents, PhytogenicNeural TubeAntibodies, MonoclonalDose-Response Relationship, DrugMifepristoneDisease ProgressionTumor Cells, CulturedTime FactorsUterusEstradiolHormone AntagonistsTumor Suppressor Protein p53Mycoplasmataceae